-+ 0.00%
-+ 0.00%
-+ 0.00%

Indivior Pharmaceuticals Affirms FY2026 Sales Guidance of $1.295B-$1.365B vs $1.334B Est

Benzinga·10/29/2026 11:05:20
Indivior Pharmaceuticals (NASDAQ:INDV) affirms FY2026 sales outlook from $1.295 billion-$1.365 billion to $1.295 billion-$1.365 billion vs $1.334 billion estimate.